WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Nenad Bursac, Ph.D., Rooney Family Associate Professor of Biomedical Engineering and Cardiology, Biomedical Engineering/Division of Cardiology, Duke University, to its College of Fellows. Dr. Bursac was nominated, reviewed, and elected by peers and members of the College of Fellows For outstanding contributions to the fields of somatic- and stem cell-based therapies for cardiac and skeletal muscle disease.
Scientists at Duke University announced this week that human skeletal muscle has been successfully grown in the laboratory that is able to react to stimuli just like native tissue.
The lab-grown muscle will allow researchers to study the effects that drugs and disease have on muscle tissue without having to endanger the health of a potential patient, reports Science Daily.
“The beauty of this work is that it can serve as a test bed for clinical trials in a dish,” says Nenad Bursac, associate professor of biomedical engineering at Duke University.
Bursac said the development would hopefully allow doctors to begin prescribing personalized medicine to patients in the future.
“We can take a biopsy from each patient, grow many new muscles to use as test samples and experiment to see which drugs would work best for each person,” he explained.